Patent List of Stephane Bancel, Moderna CEO

I searched for his patents and categorized them with the patent family. A total of 219 patent applications were extracted.

Apr 22, 2024

Moderna CEO Stephane Bancel's patents have been highly controversial because they openly teach us about the risks associated with the mRNA vaccine, as featured on the Substack of Mr. McKernan.

Nepetalactone Newsletter

Patent tour and freezer clean out

Our freezers are full. In attempt to clean house I have noticed a few other vax related material sent to us that the team needs to dispose of. Before they are disposed of, I threw them through their final qPCR. FL0007 was fully consumed making an Oxford Nanopore library. That sequencing has already been…

a year ago · 84 likes · 10 comments · Anandamide

Stephane Bancel's fatal testimony can be mainly found in the BACKGROUND section of the patent specification. This is related to the issue of "legal self-acknowledgement" that often arises when drafting the patent specification. Generally, "the problem to be solved by the invention" and "the problem of the prior art" are described in this section, and the invention described in the specification (Claim section) is to be a means to solve the problem.

By thoroughly describing the BACKGROUND section (problem to be solved by the invention), the invention capable of solving the big problem appears to be a better invention and more likely to be patented.

However, this is an illusion.

This directly leads to the disclosure of the technical problem which the inventor actually knew at the patent filing date, and may affect future own products.

The invention for which a patent right has been granted constitutes an intangible movable property right, and the matters stated in the specification legally bind the applicant and the inventor. For example, the matters stated in the patent specification should be bound by the principle of good faith and the doctrine of estoppel.

Therefore, when describing a background of an invention or a prior art in a patent specification, an extreme care must be taken to avoid giving rise to "legal self-acknowledgement." The matters to be described in the BACKGROUND section (problem to be solved by the invention) should be kept to the minimum necessary for obtaining a patent right, and statements not related to the patent right should be omitted.

Unfortunately, Stephane Bancel's patents neglect those matters.

His patents with fatal confessions fall into the following three categories.

(1) "OFFSPRING" PATENT

(2) "ENDOTOXIN" PATENT

(3) "RESIDUAL DNA & qPCR" PATENT

(1) The "OFFSPRING" PATENT teaches us that DNA introduced into a cell can be inherited by daughter cells or by offspring.

e.g. WO2013151663A1

(2) The "ENDOTOXIN" PATENT teaches us that the endotoxin contamination is detrimental to patient safety and therefore a process that introduces endotoxin into a drug substance is generally not viable for use in patients. The endotoxin is a toxi

e.g. WO2014152031A1

(3) The "RESIDUAL DNA & qPCR" PATENT teaches us that the DNA template used in the mRNA manufacturing process must be removed because it has the potential to be oncogenic in patient populations. Also, this patent teaches us that the qPCR underestimates the residual DNA.

e.g. WO2014152030A1

Moderna uses qPCR in their manufacturing process, in spite of this patent, so this patent seems to be relatively deadly.

From Information regarding the COVID-19 vaccine Moderna intramuscular injection (see P. 109).

From EMA/15689/2021 Corr.1 (P. 19/169)

The reason why I focused on his patents this time is to respond to the public question as to whether there are other fatal patent applications filed by him. Although I couldn't find any particularly new findings, let me report this as one important result (see the list attached below).

I searched for his patents and categorized them with the patent families. The List of these patents linked to the Google Patents is attached at the bottom of this post.

Total of 219 patent applications were extracted. Some patents do not include him as an inventor although they belong to the patent family.

There were 145 "OFFSPRING" PATENTs, accounting for 2/3 of the total.

There were 6 "ENDOTOXIN" PATENTs (see Patent family 4).

There were 5 "RESIDUAL DNA & qPCR" PATENTs (see Patent family 7).

Those include the patent applications claiming priority and the divisional (continuation) applications, but I have never seen so many patent applications filed by a single inventor (even a joint inventor).

NOTE:

For convenience, I have extracted the International patents (WO), the European patents (EP), and the United States patents (US), and other patent families including Australian patent (AU), Japanese patent (JP), Chinese patent (CN), etc., are excluded from the list.

The "A" at the end of the patent number means the "patent publication number." The "B" may be added to the end of a patent number, which means a "registration number." The A-status and the B-status patent specifications typically disclose the same content, except for the scope of the Claims.

I could have extracted the B status patents, but as is clear from the number of patent applications, but the process of checking for overlaps between A-status and B-status patent specifications is extremely time-consuming. Also, there are patents that have been published but not registered.

So, I excluded the B-status. That is, all we need to know are just the published technical contents. We can easily find out whether A-status patent is registered or not from Google patent, etc.

The patent search requires an advanced know-how (unfortunately I don’t have), so there is no guarantee that all patents are correctly extracted. Therefore, there may be patents missing from this list. If you find a patent of Stephane Bancel, please let me know to create a list that serves the public interest. That will be reflected in the following list.

The patent families I'm interested in and going to check more are highlighted by markers, etc. Blue texts indicate patents other than the "OFFSPRING" PATENTs in Family 1.